The publication of science involves conscientious, systematic and comprehensive processes by publishers and editors which require to be dealt with efficiently and competently. To maintain high ethical standards of publication of quality science the publisher strives to work closely at all times with journal editors, authors and peer-reviewers. The ethics statement for Bentham Science Publishers (BSP) journals is based on those by the Committee on Publication Ethics (COPE) Code of Conduct guidelines available at www.publicationethics.org.
The essentials of BSP’s publishing ethics for all groups involved in the publishing process are as follows:
The editor of a journal holds a vital position taking important editorial decisions on all peer-reviewed submitted for publication.
The editor should maintain the transparency of the academic research & record, preclude professional needs from cooperating ethical standards, and always be willing to publish retractions, rectifications, and erratum when required.
The editor should assess manuscripts for their scientific quality and intellectual content, free from any sort of biased decisions based on discrimination of race, gender, geographical origin, or religion of the author(s). The editor should evaluate manuscripts objectively based on their academic merit free of any commercial or self-interests.
The editor should not disclose any information on submitted manuscripts before publication of the manuscript.
Promoting research rectitude must be preserved. If at any stage the publisher suspects any kind of misconduct in research, it should be investigated promptly in detail with suitable authority; and if any suspicious act of misconduct is observed in the peer review, it should be resolved with diligence.
Providing a detailed, constructive, and unbiased evaluation in a timely manner on the scientific content of the work.
Indicating whether the writing is relevant, concise & clear and evaluating the originality and scientific accuracy.
Maintaining the confidentiality of the complete review process.
Notifying the journal editor about any financial or personal conflict of interest and declining to review the manuscript when a possibility of such a conflict exists.
Notifying the journal editor of any ethical concerns in their evaluation of submitted manuscripts; such as any violation of ethical treatment of animal or human subjects or any considerable similarity between the previously published article and any reviewed manuscript.
All the work reported in the manuscript must be original and free from any kind of plagiarism.
The work should not have been published elsewhere or submitted to any other journal(s) at the same time.
Any potential conflict of interest must be clearly acknowledged.
Proper acknowledgements to other work reported (individual/company/institution) must be given. Permission must be obtained from any content used from other sources.
Only those who have made any substantial contribution to the interpretation or composition of the submitted work, should be listed as ‘Authors’. While other contributors should be mentioned as ‘co-authors’.
BSP is committed to work with journal editors, defining clearly their relevant roles, in order to ensure appropriate decisions regarding publication procedures and maintaining the transparency of editorial decisions.
BSP ensures the integrity autonomy and originality of each published article with respect to:
publication and research fundings
publication ethics and rectitude
conflicts of interest
timely publication of content.
Manuel Velasco Departamento de Ciencias Biomédicas Central University of Venezuela Caracas (Venezuela) Biography
Biography of Manuel Velasco
Manuel Velasco, M.D., is a Professor of Pharmacology at the Central University of
Venezuela, School of Medicine, and Director of Clinical Pharmacology Unit (CPU) at the
Vargas School of Medicine in Caracas, Venezuela. Before joining to CPU, he obtained his
Fellowship in Medicine at Emory University School of Medicine, Atlanta, USA. Dr. Velasco
obtained his Fellowship at the Royal College of Physicians of Edinburgh. and acquired
considerable experience in the areas of nuclear transfer, embryonic stem cells, embryo
micromanipulation and state-of-the-art genetic engineering techniques in Biostatistics,
radioisotopes and advanced Clinical pharmacology in the Royal College of Physicians in
Edinburgh, Scotland, UK.
He has contributed significantly in the understanding of Endogenous Amines in blood
pressure control, and his observations on anti-hypertensive drugs have helped spark the
renewed interest in clinical pharmacology of this disease.
He has also served as a member of the Editorial Board or Reviewer ad hoc of the
following international journals: Hypertension, the Journal of Cardiovascular
Pharmacology, Clinical Pharmacology and Therapeutics, the Journal of Hypertension , the
Journal of Clinical Pharmacology. He also serves as a Member of the Editorial Board of
the American Journal of Therapeutics and reviewer ad hoc of the Journal of Hypertension
and the Journal of Clinical Pharmacology.
Dr. Velasco has edited several international congress series of Elsevier(The Netherlands)
In the area of Cardiovascular Physiology, Hypertension, Clinical Pharmacology and
Therapeutics and Internal Medicine.
Among his activities have being the founding of numerous scientific societies: Venezuelan
Society of Pharmacology, Venezuelan Society of Clinical Pharmacology, Interamerican
Society of Clinical Pharmacology, Latinamerican Society of Hypertension, Venezuelan
Society of Hypertension and Interamerican Society of Diabetes
He also serves as Editor-in-Chief of two of the most accredited Scientific Journals in Latin
America: “Archivos Venezolanos de Farmacología y Terapeutica” y la “Revista
Latinoamericana de Hipertensión”. Dr. Velasco is one of the top scientists involved in
Hypertension and Clinical Pharmacology combining years of extensive research and
Dr Velasco is an author and co-author of many scientific papers in the field of
cardiovascular diseases and metabolic syndrome diseases(Hypertension, prediabetes,
diabetes, obesity, insulin resistance, dyslipidemias, etc)